In this study we chose to use a gene, vimentin, in which increases in methylation have demonstrated a strong correlation with the development of colon cancer, and that has been used as the target for a commercialized fecal DNA methylation diagnostic test (ColoSure, LabCorp). Here, VIM is linked to malignant colon neoplasm.